attention deficit hyperactivity disorder. Attention-deficit hyperactivity disorder, predominantly inattentive type
Conditions
Interventions
Intervention 1: Intervention group: Bioflora capsules (Active substance: lactobacillus acidophilus, bifidobacterium bifidum, bifidobacterium lactis, bifidobacterium longum and other ingredients: Magne
for two months (one per day), 1.8 × 109 CFU/Capsule. Intervention 2: Control group: Placebo consumption is intended for two months (one per day) for each participant. Placebo is produced by Tak Zhen Z
Sponsors
Guilan University of Medical Sciences, Vice-Chancellor for Research & Technology
Eligibility
Sex/Gender
All
Age
7 Years to 12 Years
Inclusion criteria
Inclusion criteria: Diagnosis of attention deficit- hyperactivity disorder 7-12 years old having informed consent to participate in research having normal IQ rate (85 to 115) children under standard treatment with Ritalin Body mass less than +2 standard deviation
Exclusion criteria
Exclusion criteria: Having Psychiatric and medical comorbid disorders simultaneous use of supplements or drugs that interfere with treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Executive functions. Timepoint: Before intervention, after intervention, two months after intervention. Method of measurement: BRIEF' Executive Function Questionnaire (parent form).;Attention deficit. Timepoint: Before intervention, after intervention, two months after intervention. Method of measurement: Swanson, Nolan and Pelham Rating Scale (SNAP-IV).;Hyperactivity. Timepoint: Before intervention, after intervention, two months after intervention. Method of measurement: Swanson, Nolan and Pelham Rating Scale (SNAP-IV).;Impulsivity. Timepoint: Before intervention, after intervention, two months after intervention. Method of measurement: Swanson, Nolan and Pelham Rating Scale (SNAP-IV). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Rabipour
Islamic Azad University
Outcome results
None listed